Abnormal sleep patterns, like those of night-shift workers, disrupt the body's natural biological clock and have been linked to lung health issues. A new study by University of Rochester Medical Center (URMC) researchers ...
Apr 17, 2023
0
44
Johns Hopkins Medicine scientists say their 20-year study of more than 200 people with premature aging syndromes caused by abnormally short telomeres, or shortened repetitive DNA sequences at the ends of chromosomes, may ...
Mar 30, 2023
0
77
Stanford Medicine researchers have found a mechanism behind one of the most common symptoms of long COVID—shortness of breath. Post COVID-19 breathing problems are caused by a condition known as lung fibrosis, when damaged ...
Mar 20, 2023
0
129
Pulmonary fibrosis is a devastating disease characterized by progressive scarring in the lungs, killing up to half of patients within five years of a diagnosis. Little is known about whether there are differences in how the ...
Mar 10, 2023
1
47
Chest CT revealed persistent lung abnormalities in patients two years after COVID-19, according to a study published in Radiology. This is the first research paper with two-year follow-up data on COVID-19 lung effects.
Feb 14, 2023
0
16
Pathogens such as SARS-CoV-2 and pneumococcus can cause severe pneumonia. If the airways then fill with fluid, the patient risks developing acute respiratory distress syndrome. Researchers at Charité—Universitätsmedizin ...
Dec 22, 2022
0
102
New research published in Cell Death & Disease covers the first batch of results from collaborative work directed to perform multi-omics-based analyses in the context of age-related diseases using an AI-driven target and ...
Dec 1, 2022
0
4
Researchers at National Jewish Health have shown that vapor from electronic cigarettes increases small airway inflammation response to influenza A infections. The findings show that short-term exposure of just three days ...
Nov 14, 2022
0
11
An international team of researchers has revealed how scarring occurs in long COVID and pulmonary fibrosis using innovative blood biomarkers and X-ray technology. This study, published in eBioMedicine, contributes to the ...
Nov 2, 2022
0
5
Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical ...
Oct 13, 2022
1
37
